# Study of Efficacy & Safety of Oral YM087 in Subjects With Euvolemic or Hypervolemic Hyponatremia

> **NCT00492037** · PHASE3 · COMPLETED · sponsor: **Cumberland Pharmaceuticals** · enrollment: 83 (actual)

## Conditions studied

- Hyponatremia

## Interventions

- **DRUG:** YM087 oral

## Key facts

- **NCT ID:** NCT00492037
- **Lead sponsor:** Cumberland Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-01
- **Primary completion:** —
- **Final completion:** 2002-02
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2014-05-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00492037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00492037, "Study of Efficacy & Safety of Oral YM087 in Subjects With Euvolemic or Hypervolemic Hyponatremia". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00492037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*